APOTHEEK DRONGEN

Active

Private limited companyfounded 1996active for 30 yearsMariakerksesteenweg 80A, 9031 Gent, BelgiumKBO/BCE: BE 0458.279.765

Summary

The computed 12-month bankruptcy probability of APOTHEEK DRONGEN is 2.0% (moderate). The 2025 annual accounts show negative equity (-€193,664) and a net result of -€79,719. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 12% of 812 sector peers (NACE 74, financial year 2025). The company has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

APOTHEEK DRONGENActiveChecked score 52/100

Risk analysis Report Compare

Activity

Translation services

NACE 74301Retail sale of pharmaceutical products NACE 47730

1 site

Size

€1.0mtotal assets 2025

Staff: 3.7 FTE
Equity: -€193,664
Loss: -€79,719

Turnover not published (abbreviated format)

Financial health

52 Fair Checked score 2025

Bankruptcy probabilitywithin 12 months: 2.0%

Structure

Parent: GROEP DF · 100%

GROEP DFDirector

2025 accounts 14 days early2 of 6 deeds summarised

Why 52raises riskNegative equity -€193,6641 change of registered office in 24 monthsLoss of €79,719, the second in a row (financial year 2025)lowers riskSector: Other professional, scientific and technical activities (NACE 74)Show the evidence

Checked score

Score 2025

52 / 100

Fair

Probability in this band: 1.5% to 4.2%

Financially better than 17% of its sector peers (NACE 74, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Weak

Solvency 6-7

equity -18.6% of total assets

Liquidity 43+4

short-term debt 35.1% · cash 6.6%

Profitability 20-10

return on assets -7.7%

Bankruptcy probability, 12 months

2.0% Moderate

0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (5,417 companies, NACE 74, micro)

Last 24 months 11-2024: 3.1% 12-2024: 3.1%● unchanged vs 11-2024 01-2025: 3.1%● unchanged vs 12-2024 02-2025: 3.1%● unchanged vs 01-2025 03-2025: 3.1%● unchanged vs 02-2025 04-2025: 3.0%▼ -0.1 percentage points vs 03-2025 05-2025: 2.9%▼ -0.1 percentage points vs 04-2025 06-2025: 2.7%▼ -0.2 percentage points vs 05-2025 07-2025: 2.9%▲ +0.2 percentage points vs 06-2025 08-2025: 1.6%▼ -1.3 percentage points vs 07-2025 09-2025: 1.6%● unchanged vs 08-2025 10-2025: 1.6%● unchanged vs 09-2025 11-2025: 1.6%● unchanged vs 10-2025 12-2025: 1.6%● unchanged vs 11-2025 01-2026: 4.6%▲ +3.0 percentage points vs 12-2025highest value 02-2026: 1.6%▼ -3.0 percentage points vs 01-2026 03-2026: 1.6%● unchanged vs 02-2026 04-2026: 1.5%▼ -0.1 percentage points vs 03-2026 05-2026: 1.6%▲ +0.1 percentage points vs 04-2026 06-2026: 1.5%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: 1.6%▲ +0.1 percentage points vs 06-2026 08-2026: 2.0%▲ +0.4 percentage points vs 07-2026 09-2026: 2.0%● unchanged vs 08-2026 10-2026: 2.0%● unchanged vs 09-2026

No credit on open account

Liquidity insufficient (current ratio 0.92, compared with 0.77 in 2024, below 1; short-term debt: 35.1% and cash: 6.6% of total assets), and equity is negative.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 74, micro): better than 12% on solvency, 26% on liquidity, 20% on profitability and 9% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Negative equity -€193,664

NBB · annual accounts

1 change of registered office in 24 months

Belgian Official Gazette

Loss of €79,719, the second in a row (financial year 2025)

NBB · annual accounts

Sector: Other professional, scientific and technical activities (NACE 74)

KBO

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year -€193,664

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

14 days early

2024

13 days early

2023

13 days early

2022

30 days late

2021

18 days late

2020

31 days late

2019

24 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days after the deadline; the sector median (NACE 74) for financial year 2024 is 3 days before the deadline, and 38% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 July (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

25-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

17-07-2026 Annual accounts filedfinancial year 2025 · abbreviated…
29-12-2025 Permanent representative: VAN CLEEMPUT DiederikRegistered-office move
18-07-2025 Annual accounts filedfinancial year 2024 · abbreviated…

Key points

Risk: Negative equityfinancial year 2025: debts exceed assets -€193,664 View
Risk: 3 loss-making years in a rowloss financial year 2025 -€79,719 View
Caution: Among the weakest 5% on equitysector median €102,859 · 812 companies -€193,664 View
Caution: Equity fell in 2025from -€113,944 to -€193,664 ▼ 70.0% View
Controlled by GROEP DF 100% View

By topic

Financials

Financial year: 2025
Total assets: €1.0m
Loss: -€79,719
Solvency: -18.6%

Total assets▲ 11.6%

Net result

20182025

Go to Financials

Board & ownership

Board: 1 member
Parent: GROEP DF · 100%

GROEP DFDirector

Go to Board & ownership

Timeline

Events: 34
Since: 1998
Next accounts: by 31-07-2027

18-07-2024Annual accounts filed
30-01-2024Resignation: GROEP DF (manager)
31-12-2023Weakest financial year

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Translation servicesNACE 74301
Founded: 12-07-1996
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 34

Who signs: Each director alone
Annual meeting: Third Wednesday of June at 10:00
Purpose: “De uitbating van apotheken,; De aan- en verkoop, de invoer en uitvoer, de handel in, de…” (deed in Dutch)

Go to Articles of association

Key facts about APOTHEEK DRONGEN

What is the company number of APOTHEEK DRONGEN?: 0458.279.765. In Belgium the VAT number is the company number with BE in front: BE 0458.279.765.
Where is APOTHEEK DRONGEN based?: The registered office is at Mariakerksesteenweg 80A, 9031 Gent.Company details
What does APOTHEEK DRONGEN do?: According to the KBO register, the main activity is translation services (NACE 74301).
What is the legal form of APOTHEEK DRONGEN?: Private limited company (BV).
When was APOTHEEK DRONGEN founded?: On 12-07-1996.
Is APOTHEEK DRONGEN still active?: Yes, APOTHEEK DRONGEN is an active enterprise in the KBO register.
How many employees does APOTHEEK DRONGEN have?: On average 3.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK DRONGEN?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK DRONGEN profitable?: In financial year 2025, APOTHEEK DRONGEN made a loss of €79,719.
Where can I find the annual accounts of APOTHEEK DRONGEN?: APOTHEEK DRONGEN filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK DRONGEN due?: By 31-07-2027, for financial year 2026.Timeline